Improved oral bioavailability, cellular uptake and cytotoxic activity of zingerone via nano-micelles drug delivery system
Herein, a nano-micelle drug delivery system was developed to orally improved zingerone’s bioavailability and its antitumor effect. Indeed, zingerone-loaded D-α-tocopheryl polyethylene glycol succinate micelles (ZTMs) were effectively prepared, characterised and assessed. The ZTMs had diameter, polydispersity index and zeta potential of 50.62 ± 0.25 nm, 0.168 ± 0.006 and −28.07 ± 0.33 mV respectively, coupled with a high entrapment efficiency (m/m, %) were 94.71 ± 2.02.
The release rate of ZTMs in three media was significantly greater than that of free zingerone. Intriguingly, results obtained from pharmacokinetic studies showed that the oral bioavailability of the ZTMs was enhanced by 5.10 times in comparison with the free zingerone. Further, the half inhibitory concentration (IC50) of ZTMs and free zingerone was 7.56 μg/mL and 14.30 μg/mL, respectively on HepG2 cells. Hence, ZTMs may be used as a potential approach to enrich the solubility, bioavailability, and concomitant anti-proliferative effect of zingerone in vitro.
Article information: (2021) Improved oral bioavailability, cellular uptake and cytotoxic activity of zingerone via nano-micelles drug delivery system, Journal of Microencapsulation, DOI: 10.1080/02652048.2021.1957036
More about Vitamin E TPGS: